Ralph A. Loren: Lawyer with Edwards Wildman Palmer LLP

Ralph A. Loren

Of Counsel
Boston,  MA  U.S.A.

Peer Rating
AV® Preeminent

Client Rating

Featured AV Peer Review Rated Lawyer IconFeatured AV Peer Review Rated Lawyer Icon
Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials Ratings & Reviews

Practice Areas

  • Intellectual Property
  • Patents
  • Trademark and Trade Dress
  • IP Litigation
  • Business Law
  • Licensing
  • Healthcare
  • Collaborations
  • Joint Ventures & Strategic Alliances
  • Technology
  • Media & Telecommunications
  • Life Sciences
  • Educational Institutions
University Tufts University (B.S., magna cum laude, 1972; M.S., 1977); University of California, Graduate Student, 1973
Law SchoolBoston University School of Law, J.D., cum laude, 1979
AdmittedMassachusetts; U.S. Patent & Trademark Office; U.S. Court of Appeals, Federal Circuit; U.S. Court of Appeals, First Circuit; U.S. District Court, District of Massachusetts; Massachusetts Supreme Judicial Court


American Bar Association
Boston Bar Association
Boston Patent Law Association
American Intellectual Property Law Association


Ralph Loren, has practiced in all phases of intellectual property for over 35 years. His practice is primarily in litigation and deal work with an emphasis on licensing and due diligence. He has many years of patent prosecution experience, primarily in the life sciences and computer fields. He has litigated numerous patent infringement actions in diverse fields including biotechnology, chemical analyzers, computers, electronic equipment and mechanical devices. He has been involved in a number of interferences in the biotechnology and chemical/mechanical field. He has also litigated numerous trademark and copyright matters. His deal experience ranges from M&A and licensing in the pharma space to licensing and due diligence in the software field.

Ralph lectures around the country on a variety of patent, licensing and litigation topics, including arbitration issues. He was a part-time professor at Boston University School of Law, where he taught patent law. He was also the author of a chapter entitled “Alternative Dispute Resolution” in the multi-volume Mathew Bender series, “Intellectual Property Counseling and Litigation.” He is listed as one of the leading Intellectual Property Attorneys in Massachusetts in Chambers USA and has been included in the Massachusetts Super Lawyers listing, a Thomson Reuters publication, numerous times. Ralph is also rated AV Preeminent by Martindale-Hubbell.


Edwards Wildman Team Leads Merger of Vision Insurance Companies

In July 2013, an Edwards Wildman deal team led by Andrew Hughes and Paul Mahoney of our Providence office represented clients Nautic Partners, a private equity firm with than $2.5 billion of capital under management, and Superior Vision, a Nautic Partners portfolio company based in California, in Superior Vision's execution of a merger agreement providing for the acquisition of Block Vision, a Maryland-based national provider of vision insurance coverage.

PTC Inc. Acquisition of Software Developer

A large team of Edwards Wildman lawyers represented longtime client PTC in its acquisition of Enigma Information Systems Ltd., an Israeli software developer.

Stemline Therapeutics, Inc IPO

In January 2013, Edwards Wildman corporate, finance, insurance and intellectual property team members from Boston and Chicago advised Stemline Therapeutics, Inc. on its Initial Public Offering.

Represented Nautic Partners in its Acquisition of a Vision Insurance Company

We represented Providence, RI-based Nautic Partners, a private equity firm, in a March 2012 leveraged acquisition of Superior Vision Holdings, Inc.

Euroscreen S.A. license agreement

Our Intellectual Property lawyers advised Euroscreen, S.A. in the license of technology and compounds to Ortho-McNeil-Janssen Pharmaceuticals,Inc. Euroscreen is a private Belgian, preclinical-stage company that engages in drug discovery and development of small molecule drugs for unmet medical needs including inflammation, metabolism and sex hormone modulation.

Edwards Wildman's Ralph Loren and Dave Cotta Examine Whether the Federal Circuit Will Reverse the PTAB's Decisions in Intellectual Property Magazine article
June 2014
Edwards Wildman Client Advisory - Limelight v. Akamai: Illuminating Inducement of Patent Infringement
June 3, 2014
Edwards Wildman's Ralph Loren and Gabe McCool Examine How the PTAB Use Of Redundancy May Have Unfair Estoppel Effect in Law360
March 21, 2014
Edwards Wildman Client Advisory - U.S. Patent and Trademark Office Issues Guidance in View of Prometheus and Myriad
March 2014
Starting and Growing a Technology or Life Sciences Company
February 28, 2014 event
Edwards Wildman Client Advisory: Fresenius v. Baxter International: Riding Cross-Currents of Collateral Estoppel in a New Age of Patent Challenges at the USPTO
August 2013
Edwards Wildman Client Advisory: First PTAB Decision Highlights Tension Between District Court and USPTO Litigation
June 26,2013
Edwards Wildman Client Advisory: Supreme Court Invalidates Claims to Isolated DNA, but Upholds Patent Eligibility of cDNA in Myriad
June 2013
The Changing Face of the IP Market
June 10, 2013 event
2013 IP Business Congress
June 9 -11, 2013 event

Edwards Wildman's Ralph Loren Weighs In On High Court's Induced Infringement Ruling in Law360
June 3, 2014
Edwards Wildman's Boston Team Conducts 'Master Class' for Biotech Startups
March 11, 2014
Edwards Wildman's Ralph Loren Analyzes How China is Fuelling Surge in Global IP Growth in World Intellectual Property Review
December 11, 2013
Edwards Wildman's Ralph Loren Comments on FTC Inquiry into Patent Assertion Entities in World Intellectual Property Review
October 2, 2013
Edwards Wildman's Ralph Loren Comments on Application for Drug Patent in India in World Intellectual Property Review
August 21, 2013
Edwards Wildman's Ralph Loren Analyze Impact of Federal Circuit Ruling on Collateral Estoppel in Law360
August 21, 2013
Edwards Wildman's Ralph Loren Examine Versata Ruling in Law360
July 8, 2013
Edwards Wildman's Ralph Loren Analyzes Myriad Decision in Law360
June 14, 2013
Edwards Wildman's Ralph Loren Analyzes Shire Settlement with Teva over ADHD Drug in Life Sciences Intellectual Property Review
June 4, 2013
Edwards Wildman's Ralph Loren Weigh In On Supreme Court's Monsanto Ruling in Law360
May 14, 2013


Documents by this lawyer on Martindale.com

Subscribe to this feed

Limelight v. Akamai: Illuminating Inducement of Patent Infringement
Jeffrey D. Hsi,Ralph A. Loren, June 11, 2014
On June 2, the Supreme Court issued a decision regarding inducing infringement, Limelight Networks, Inc. v. Akamai Technologies, Inc., et al., (12-786). The Justices, reversing and remanding the widely split en banc decision from the Federal Circuit, held that one could not support a finding of...

U.S. Patent and Trademark Office Issues Guidance in View of Prometheus and Myriad
Daniel W. Clarke,Peter F. Corless,Christopher R. Cowles,Ralph A. Loren, March 11, 2014
On March 4, 2014, the United States Patent and Trademark Office (USPTO) issued a highly anticipated Guidance for Determining Subject Matter Eligibility of Claims Reciting or Involving Laws of Nature, Natural Phenomena & Natural Products (“Guidance”). The Guidance is promulgated for...

View Ratings & Reviews
Profile Visibility
#1,508 in weekly profile views out of 19,871 lawyers in Boston, Massachusetts
#111,830 in weekly profile views out of 1,616,736 total lawyers Overall

Office Information

Ralph A. Loren

111 Huntington Avenue
BostonMA 02199-7613


Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now